Literature DB >> 26566916

Treatment of SPG5 with cholesterol-lowering drugs.

Andrea Mignarri1, Alessandro Malandrini1, Marina Del Puppo2, Alessandro Magni2, Lucia Monti3, Federica Ginanneschi1, Alessandra Tessa4, Filippo Maria Santorelli4, Antonio Federico1, Maria Teresa Dotti5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26566916     DOI: 10.1007/s00415-015-7971-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Liver disease in infancy caused by oxysterol 7 α-hydroxylase deficiency: successful treatment with chenodeoxycholic acid.

Authors:  Dongling Dai; Philippa B Mills; Emma Footitt; Paul Gissen; Patricia McClean; Jens Stahlschmidt; Isabelle Coupry; Julie Lavie; Fanny Mochel; Cyril Goizet; Tatsuki Mizuochi; Akihiko Kimura; Hiroshi Nittono; Karin Schwarz; Peter J Crick; Yuqin Wang; William J Griffiths; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2014-09       Impact factor: 4.982

2.  Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism.

Authors:  Andrea Mignarri; Alessandro Malandrini; Marina Del Puppo; Alessandro Magni; Lucia Monti; Federica Ginanneschi; Alessandra Tessa; Filippo Maria Santorelli; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2014-02-08       Impact factor: 4.849

3.  Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain.

Authors:  Maura Heverin; Steve Meaney; Dieter Lütjohann; Ulf Diczfalusy; John Wahren; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2005-03-01       Impact factor: 5.922

4.  Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.

Authors:  Rebecca Schüle; Teepu Siddique; Han-Xiang Deng; Yi Yang; Sandra Donkervoort; Magnus Hansson; Ricardo E Madrid; Nailah Siddique; Ludger Schöls; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2009-10-07       Impact factor: 5.922

5.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Authors:  Maria K Tsaousidou; Karim Ouahchi; Tom T Warner; Yi Yang; Michael A Simpson; Nigel G Laing; Philip A Wilkinson; Ricardo E Madrid; Heema Patel; Faycal Hentati; Michael A Patton; Afif Hentati; Philippa J Lamont; Teepu Siddique; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2008-01-18       Impact factor: 11.025

  5 in total
  5 in total

1.  Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Authors:  Ludger Schöls; Tim W Rattay; Peter Martus; Christoph Meisner; Jonathan Baets; Imma Fischer; Christine Jägle; Matthew J Fraidakis; Andrea Martinuzzi; Jonas Alex Saute; Marina Scarlato; Antonella Antenora; Claudia Stendel; Philip Höflinger; Charles Marques Lourenco; Lisa Abreu; Katrien Smets; Martin Paucar; Tine Deconinck; Dana M Bis; Sarah Wiethoff; Peter Bauer; Alessia Arnoldi; Wilson Marques; Laura Bannach Jardim; Stefan Hauser; Chiara Criscuolo; Alessandro Filla; Stephan Züchner; Maria Teresa Bassi; Thomas Klopstock; Peter De Jonghe; Ingemar Björkhem; Rebecca Schüle
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

2.  White Matter Alterations in Spastic Paraplegia Type 5: A Multiparametric Structural MRI Study and Correlations with Biochemical Measurements.

Authors:  Y Liu; Z Ye; J Hu; Z Xiao; F Zhang; X Yang; W Chen; Y Fu; D Cao
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-18       Impact factor: 3.825

3.  Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature.

Authors:  Marta Bellofatto; Giovanna De Michele; Aniello Iovino; Alessandro Filla; Filippo M Santorelli
Journal:  Front Neurol       Date:  2019-01-22       Impact factor: 4.003

Review 4.  Lipid metabolic pathways converge in motor neuron degenerative diseases.

Authors:  Olivia J Rickman; Emma L Baple; Andrew H Crosby
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

5.  Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid.

Authors:  Yun-Ping Tang; Jing-Yu Gong; Kenneth D R Setchell; Wujuan Zhang; Jing Zhao; Jian-She Wang
Journal:  BMC Gastroenterol       Date:  2021-04-13       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.